Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125728521 | 12572852 | 1 | I | 2015 | 20151023 | 20160720 | 20160720 | EXP | CA-AMGEN-CANSP2015113554 | AMGEN | 78.00 | YR | E | F | Y | 0.00000 | 20160720 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125728521 | 12572852 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, UNK | U | 103795 | 50 | MG | UNKNOWN FORMULATION | ||||||
| 125728521 | 12572852 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 125728521 | 12572852 | 3 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 125728521 | 12572852 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 125728521 | 12572852 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 20 MG, QWK | 0 | 20 | MG | /wk | |||||||
| 125728521 | 12572852 | 6 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | 0 | ||||||||||
| 125728521 | 12572852 | 7 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 200 MG, BID | 0 | 200 | MG | TABLET | BID | ||||||
| 125728521 | 12572852 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 125728521 | 12572852 | 9 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | 1000 MG, BID | 0 | 1000 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125728521 | 12572852 | 1 | Rheumatoid arthritis |
| 125728521 | 12572852 | 2 | Product used for unknown indication |
| 125728521 | 12572852 | 3 | Product used for unknown indication |
| 125728521 | 12572852 | 4 | Product used for unknown indication |
| 125728521 | 12572852 | 5 | Rheumatoid arthritis |
| 125728521 | 12572852 | 6 | Product used for unknown indication |
| 125728521 | 12572852 | 7 | Rheumatoid arthritis |
| 125728521 | 12572852 | 8 | Product used for unknown indication |
| 125728521 | 12572852 | 9 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125728521 | 12572852 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125728521 | 12572852 | Activities of daily living impaired | |
| 125728521 | 12572852 | Adverse drug reaction | |
| 125728521 | 12572852 | Arthralgia | |
| 125728521 | 12572852 | Back pain | |
| 125728521 | 12572852 | Condition aggravated | |
| 125728521 | 12572852 | Drug ineffective | |
| 125728521 | 12572852 | Fatigue | |
| 125728521 | 12572852 | Joint swelling | |
| 125728521 | 12572852 | Pain | |
| 125728521 | 12572852 | Peripheral swelling | |
| 125728521 | 12572852 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125728521 | 12572852 | 1 | 20130618 | 201309 | 0 | |
| 125728521 | 12572852 | 3 | 20130313 | 0 | ||
| 125728521 | 12572852 | 5 | 20130130 | 0 | ||
| 125728521 | 12572852 | 7 | 20121213 | 0 | ||
| 125728521 | 12572852 | 8 | 20130313 | 0 | ||
| 125728521 | 12572852 | 9 | 20121213 | 0 |